Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Barely Naked

The Truth About Ozempic and Co. with Dr. Omar Babar

15 Apr 2025

Description

In this episode, Dr. Omar Babar joins Christina to talk about all things Ozempic, weight loss injections, and the future of health treatments. Omar is a medical director at Healand Clinic and has spent over 14 years working in the NHS. He shares how his clinic offers innovative options that go beyond what’s usually available – and how these treatments are helping people make real, lasting changes in their health.We dive into how weight loss injections like Ozempic actually work, who they’re for, and what to keep in mind when using them long-term. Omar explains how microdosing these medications can even help with inflammation, autoimmune conditions, PCOS and addiction, and why professional support is key.We also talk about the growing interest in NAD treatments, the risks of ordering medication online, and how body image pressures are shaping people’s choices. Whether you're curious about these injectables, considering treatment, or just want to understand the bigger picture, this episode offers a clear and honest look at what’s really going on.About Dr. Omar BabarDr. Omar Babar is the Medical Director at Healand Clinic, a forward-thinking health practice in Leicester, UK. With over 14 years of medical experience, Omar combines traditional and modern approaches to help people feel better, safely and sustainably.How to get in touch with OmarWebsite: healand.co.uk⁠Instagram:@healandclinic ⁠How to get in touch with ChristinaInstagram: @christina_simoneTikTok: @barely_naked_podcastLinkedIn: Christina Beischl

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.